These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1455374)

  • 1. [Pulse therapy with methylprednisolone and cyclophosphamide in systemic juvenile rheumatoid arthritis: the results of an open, parallel, controlled, randomized, 12-month study].
    Maksimov AA; Shaĭkov AV; Speranskiĭ AI; Solov'ev SK
    Ter Arkh; 1992; 64(5):47-51. PubMed ID: 1455374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repetitive use of pulse therapy with methylprednisolone and cyclophosphamide in addition to oral methotrexate in children with systemic juvenile rheumatoid arthritis--preliminary results of a longterm study.
    Shaikov AV; Maximov AA; Speransky AI; Lovell DJ; Giannini EH; Solovyev SK
    J Rheumatol; 1992 Apr; 19(4):612-6. PubMed ID: 1593584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis.
    Ruperto N; Lovell DJ; Cuttica R; Wilkinson N; Woo P; Espada G; Wouters C; Silverman ED; Balogh Z; Henrickson M; Apaz MT; Baildam E; Fasth A; Gerloni V; Lahdenne P; Prieur AM; Ravelli A; Saurenmann RK; Gamir ML; Wulffraat N; Marodi L; Petty RE; Joos R; Zulian F; McCurdy D; Myones BL; Nagy K; Reuman P; Szer I; Travers S; Beutler A; Keenan G; Clark J; Visvanathan S; Fasanmade A; Raychaudhuri A; Mendelsohn A; Martini A; Giannini EH; ;
    Arthritis Rheum; 2007 Sep; 56(9):3096-106. PubMed ID: 17763439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
    Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
    Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis.
    Silverman E; Spiegel L; Hawkins D; Petty R; Goldsmith D; Schanberg L; Duffy C; Howard P; Strand V
    Arthritis Rheum; 2005 Feb; 52(2):554-62. PubMed ID: 15693001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.
    Yee CS; Gordon C; Dostal C; Petera P; Dadoniene J; Griffiths B; Rozman B; Isenberg DA; Sturfelt G; Nived O; Turney JH; Venalis A; Adu D; Smolen JS; Emery P
    Ann Rheum Dis; 2004 May; 63(5):525-9. PubMed ID: 15082482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.
    Ruperto N; Murray KJ; Gerloni V; Wulffraat N; de Oliveira SK; Falcini F; Dolezalova P; Alessio M; Burgos-Vargas R; Corona F; Vesely R; Foster H; Davidson J; Zulian F; Asplin L; Baildam E; Consuegra JG; Ozdogan H; Saurenmann R; Joos R; Pistorio A; Woo P; Martini A;
    Arthritis Rheum; 2004 Jul; 50(7):2191-201. PubMed ID: 15248217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary analysis of a trial of pulse cyclophosphamide in IFN-beta-resistant active MS.
    Smith D
    J Neurol Sci; 2004 Aug; 223(1):73-9. PubMed ID: 15261565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of pulse-therapy on natural anticoagulant system of the endothelium in nonspecific aortoarteritis].
    Gur'eva MS; Baranov AA; Bagrakova SV; Nasonov EL; Zharikova DG
    Ter Arkh; 2003; 75(5):52-6. PubMed ID: 12847899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methotrexate treatment in refractory juvenile rheumatoid arthritis].
    Brik R
    Harefuah; 1998 Dec; 135(11):509-11, 567. PubMed ID: 10911466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis.
    Lovell DJ; Glass D; Ranz J; Kramer S; Huang B; Sierra RI; Henderson CJ; Passo M; Graham B; Bowyer S; Higgins G; Rennebohm R; Schikler KN; Giannini E
    Arthritis Rheum; 2006 Jul; 54(7):2235-42. PubMed ID: 16802360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathological study.
    Kawasaki Y; Suzuki J; Suzuki H
    Nephrol Dial Transplant; 2004 Apr; 19(4):858-64. PubMed ID: 15031341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis.
    Woo P; Southwood TR; Prieur AM; Doré CJ; Grainger J; David J; Ryder C; Hasson N; Hall A; Lemelle I
    Arthritis Rheum; 2000 Aug; 43(8):1849-57. PubMed ID: 10943876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study.
    Hunt PG; Rose CD; McIlvain-Simpson G; Tejani S
    J Rheumatol; 1997 Nov; 24(11):2230-2. PubMed ID: 9375889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulphasalazine in the treatment of juvenile rheumatoid arthritis: a preliminary open trial.
    Ozdogan H; Turunç M; Deringöl B; Yurdakul S; Yazici H
    J Rheumatol; 1986 Feb; 13(1):124-5. PubMed ID: 2871188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis.
    Kimura Y; Fieldston E; Devries-Vandervlugt B; Li S; Imundo L
    J Rheumatol; 2000 Aug; 27(8):2018-24. PubMed ID: 10955346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutical and immunological effects of methylprednisolone pulse therapy in comparison with intravenous immunoglobulin. Treatment in patients with juvenile chronic arthritis.
    Oppermann J; Möbius D
    Acta Univ Carol Med (Praha); 1994; 40(1-4):117-21. PubMed ID: 9355686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus.
    Baca V; Lavalle C; García R; Catalán T; Sauceda JM; Sánchez G; Martínez I; Ramírez ML; Márquez LM; Rojas JC
    J Rheumatol; 1999 Feb; 26(2):432-9. PubMed ID: 9972981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The combined intensive therapy of rheumatoid arthritis with systemic manifestations].
    Oliunin IuA; Balabanova RM; Solov'ev SK; Chiklikchi AS
    Ter Arkh; 1995; 67(8):59-62. PubMed ID: 7482340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auranofin therapy in juvenile rheumatoid arthritis: a 48-week phase II study.
    Kvien TK; Høyeraal HM; Sandstad B; Kass E
    Scand J Rheumatol Suppl; 1986; 63():79-83. PubMed ID: 3474778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.